Sempre Health secures $20 million in funding from Cencora Ventures, Echo Health Ventures, and others
Sempre Health, the leading solution for behavior-based healthcare pricing, today announced $20M in additional funding from three new investors, including Cencora Ventures and Echo Health Ventures. Existing investors including the Blue Venture Fund, UPMC Enterprises and Industry Ventures also participated.
Congratulations to Echo CEO Rob Coppedge for being named to the Global Corporate Venturing Powerlist for the fourth year in a row.
What makes Echo Health Ventures different from other corporate venture partners is that we invest under a dual mandate to drive both strategic impact and financial returns.
Additional investments from all previous strategic investors – CapitalG (Alphabet), Echo Health Ventures, Town Hall Ventures, Ascension Ventures and Redpoint – completed the round.
Cortica has secured $75 million of investment and acquired two companies, expanding its footprint across the U.S.
The new solution builds on the best parts of both SurgeryPlus and Embold Health’s work — identifying top-performing individual surgeons and physicians across the United States — to offer a tiered network that ensures their members access to high-quality care in their local markets.
Global Corporate Venturing this week honored two members of the Echo Health Ventures Strategic Investment team: Echo Partner Kurt Sheline and Echo Principal Omair Ahmed.
Telemedicine can improve access to heart care, said Jeff Wessler, MD, Founder and CEO of Heartbeat Health, on a new podcast with Oliver Wyman’s Ann Kaplan.
Medix Infusion, which creates access to infusion therapy for patients in rural, suburban and other underserved markets, has closed a $35 million Series B funding round led by Echo Health Ventures.